GATC Biotech AG
Provider of molecular biological services and innovative bioinformatics solutions for industry and academia
The company started its business as the first sequencing company in Europe, accomodated within the University of Constance in 1990. To date GATC has sequenced more than 30 genomes for industry and academy. GATC Biotech, still based in Constance (Germany) and with a subsidiary in Cambridge (UK), is toady a leading provider of molecular biological services and innovative bioinformatics solutions for industry and academia worldwide. GATC is privately owned and has been profitable ever since its foundation in 1990. The company is ISO-certified (ISO 9001:2000).
Peter Pohl (CEO)
Thomas Pohl (CTO)
Marchus Benz (COO)
Dr. Stephan Beck, Sanger Institute, Cambridge UK
Prof. Dr. Herwig Brunner, Fraunhofer Institute for Interfacial Engineering and Biotechnology
Dr. Georg Feger, Serono Pharmaceutical Research Institute, Switzerland
Prof. Dr. Christof von Kalle, Institute for Molecular Medicine and Cell Biology, University Freiburg
Prof. Dr. Hans Lehrach; Max-Planck-Institut for Molecular Genetics, Berlin
Jakob Stadler Platz 7
78467 Konstanz
Germany
Phone: +49-7531-81600
Fax: +49-7531-816081
GATC distributes and supports all software products (e.g. LasergeneTM) of DNASTAR, Inc. Madison, WI USA, GeneMarker, Mutation Surveyor, Mutation Explorer of SoftGenetics, LLC. State College, PA USA and ERGOTM), the bioinformatic suite of Integrated Genomics, Inc. Chicago, IL USA.
Besides bioinformatics solutions the company provides sequencing services, gene expression analysis and many other molecular biology services.
Related news
- GATC Biotech Opens New Subsidiary in Stockholm, Sweden
- GATC Biotech Announces Collaboration Agreement to Develop Comprehensive DNA-Based Sepsis Diagnostic
- GATC Strengthens Management Team With Appointment of Dr Marcus Benz as Chief Operating Officer
- GATC Biotech Demonstrates New DNA Sequencing Capability and Sequences 9 Bacterial Genomes in April
